These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 3163271

  • 41. Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4).
    Townsend A, Leclerc JM, Dutschman G, Cooney D, Cheng YC.
    Cancer Res; 1985 Aug; 45(8):3522-8. PubMed ID: 2410096
    [Abstract] [Full Text] [Related]

  • 42. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S, Bullock G, Nuñez G, Tang C, Ibrado AM, Huang Y, Bhalla K.
    Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
    [Abstract] [Full Text] [Related]

  • 43. Biochemical pharmacology of high dose 1-beta-D-arabinofuranosylcytosine in childhood acute leukemia.
    Avramis VI, Biener R, Krailo M, Finklestein J, Ettinger L, Willoughby M, Siegel SE, Holcenberg JS.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6786-92. PubMed ID: 3479250
    [Abstract] [Full Text] [Related]

  • 44. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
    Wang Z, Van Tuyle G, Conrad D, Fisher PB, Dent P, Grant S.
    Cancer Res; 1999 Mar 15; 59(6):1259-67. PubMed ID: 10096557
    [Abstract] [Full Text] [Related]

  • 45. Effect of cytarabine and decitabine in combination in human leukemic cell lines.
    Qin T, Youssef EM, Jelinek J, Chen R, Yang AS, Garcia-Manero G, Issa JP.
    Clin Cancer Res; 2007 Jul 15; 13(14):4225-32. PubMed ID: 17634552
    [Abstract] [Full Text] [Related]

  • 46. Modulation of cytarabine metabolism in the human promyelocytic leukemia cell line HL-60 by polyhydroxy-substituted benzohydroxamic acids.
    Howell SB, Gill S, Elford HL.
    Cancer Treat Rep; 1982 Oct 15; 66(10):1825-9. PubMed ID: 6957264
    [Abstract] [Full Text] [Related]

  • 47. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism by thymidine in human acute leukemia.
    Zittoun R, Zittoun J, Marquet J, Rustum Y, Creaven P.
    Cancer Res; 1985 Oct 15; 45(10):5186-92. PubMed ID: 4027995
    [Abstract] [Full Text] [Related]

  • 48. Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.
    Karp JE, Ross DD, Yang W, Tidwell ML, Wei Y, Greer J, Mann DL, Nakanishi T, Wright JJ, Colevas AD.
    Clin Cancer Res; 2003 Jan 15; 9(1):307-15. PubMed ID: 12538483
    [Abstract] [Full Text] [Related]

  • 49. Schedule-dependent interaction of cytarabine plus doxorubicin or cytarabine plus mitoxantrone in acute myelocytic leukemia cells in culture.
    Fountzilas G, Inoue S, Ohnuma T.
    Leukemia; 1990 May 15; 4(5):321-4. PubMed ID: 2388478
    [Abstract] [Full Text] [Related]

  • 50. Effect of thymidine on the sensitivity of cultured mouse tumor cells to 1-beta-D-arabinofuranosylcytosine.
    Harris AW, Reynolds EC, Finch LR.
    Cancer Res; 1979 Feb 15; 39(2 Pt 1):538-41. PubMed ID: 761229
    [Abstract] [Full Text] [Related]

  • 51. A novel N-hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C).
    Saiko P, Graser G, Giessrigl B, Lackner A, Grusch M, Krupitza G, Basu A, Sinha BN, Jayaprakash V, Jaeger W, Fritzer-Szekeres M, Szekeres T.
    Biochem Pharmacol; 2011 Jan 01; 81(1):50-9. PubMed ID: 20849828
    [Abstract] [Full Text] [Related]

  • 52. The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology.
    Wang LM, White JC, Capizzi RL.
    Cancer Chemother Pharmacol; 1990 Jan 01; 25(6):418-24. PubMed ID: 2311169
    [Abstract] [Full Text] [Related]

  • 53. Schedule-dependent synergistic cytotoxicity of arabinofuranosylcytosine with adriamycin or 3,6-bis(5-chloro-2-piperidinyl)-2,5-piperazinedione in cultured cells.
    Rao PN, Mahagaokar S, Freireich EJ, Loo TL, Gottlieb JA.
    Cancer Res; 1975 Nov 01; 35(11 Pt 1):2996-3000. PubMed ID: 1182694
    [Abstract] [Full Text] [Related]

  • 54. Fluorescence-labeling of nicks in DNA from leukemic blast cells as a measure of damage following cytosine arabinoside. Application to the study of regulated drug sensitivity.
    Yang GS, Wang C, Minden MD, McCulloch EA.
    Leukemia; 1994 Dec 01; 8(12):2052-9. PubMed ID: 7807994
    [Abstract] [Full Text] [Related]

  • 55. Selective destruction of cultured tumor cells with uncontrolled nuclear division by cytochalasin B and cytosine arabinoside.
    O'Neill FJ.
    Cancer Res; 1975 Nov 01; 35(11 Pt 1):3111-5. PubMed ID: 1182703
    [Abstract] [Full Text] [Related]

  • 56. Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells.
    Bauer W, Horvath Z, Höchtl T, Saiko P, Karl D, Fritzer-Szekeres M, Szekeres T.
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct 01; 23(8-9):1541-4. PubMed ID: 15571294
    [Abstract] [Full Text] [Related]

  • 57. 1-beta-D-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation.
    Ray S, Ponnathpur V, Huang Y, Tang C, Mahoney ME, Ibrado AM, Bullock G, Bhalla K.
    Cancer Chemother Pharmacol; 1994 Oct 01; 34(5):365-71. PubMed ID: 7915211
    [Abstract] [Full Text] [Related]

  • 58. Potentiation of 1-beta-D-arabinofuranosylcytosine cytotoxicity to HL-60 cells by 1,25-dihydroxyvitamin D3 correlates with reduced rate of maturation of DNA replication intermediates.
    Studzinski GP, Reddy KB, Hill HZ, Bhandal AK.
    Cancer Res; 1991 Jul 01; 51(13):3451-5. PubMed ID: 2054784
    [Abstract] [Full Text] [Related]

  • 59. Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
    Horvath Z, Saiko P, Illmer C, Madlener S, Hoechtl T, Bauer W, Erker T, Jaeger W, Fritzer-Szekeres M, Szekeres T.
    Exp Hematol; 2005 Mar 01; 33(3):329-35. PubMed ID: 15730856
    [Abstract] [Full Text] [Related]

  • 60. Metronidazole enhances the cytotoxic synergism produced by the combination of 1-beta-arabinofuranosylcytosine and cis-diamminedichloroplatinum.
    Trujillo JM, Yang LY, Gercovich G, Su YZ, Lee J.
    Anticancer Res; 1989 Mar 01; 9(6):1751-6. PubMed ID: 2627125
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.